menu search

AXNX / Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
IRVINE, Calif.--( BUSINESS WIRE )--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California. Read More
Posted: Dec 21 2022, 06:00
Author Name: Business Wire
Views: 110613

AXNX News  

Axonics, Inc. (AXNX) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 30, 2023

Axonics, Inc. (AXNX) Q3 2023 Earnings Call Transcript

Axonics, Inc. (NASDAQ:AXNX ) Q3 2023 Earnings Conference Call October 30, 2023 4:30 PM ET Company Participants Neil Bhalodkar - Vice President of Inve more_horizontal

Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates

By Zacks Investment Research
October 30, 2023

Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates

Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.05 pe more_horizontal

Why Shares of Axonics Rose Friday

By The Motley Fool
July 28, 2023

Why Shares of Axonics Rose Friday

Axonics is a medical device company that focuses on bladder and bowel dysfunction therapies. The company also upgraded its annual revenue guidance. more_horizontal

Axonics, Inc. (AXNX) Q2 2023 Earnings Call Transcript

By Seeking Alpha
July 27, 2023

Axonics, Inc. (AXNX) Q2 2023 Earnings Call Transcript

Axonics, Inc. (NASDAQ:AXNX ) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Neil Bhalodkar - Vice President of Investo more_horizontal

Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
July 27, 2023

Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates

Axonics Modulation Technologies (AXNX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This more_horizontal

Axonics, Inc. (AXNX) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 1, 2023

Axonics, Inc. (AXNX) Q1 2023 Earnings Call Transcript

Axonics, Inc. (NASDAQ:AXNX ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Neil Bhalodkar - VP of IR Raymond Cohen - CE more_horizontal

Axonics Modulation Technologies (AXNX) Reports Q1 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 1, 2023

Axonics Modulation Technologies (AXNX) Reports Q1 Loss, Tops Revenue Estimates

Axonics Modulation Technologies (AXNX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.34. This more_horizontal

Axonics, Inc. (AXNX) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 1, 2023

Axonics, Inc. (AXNX) Q4 2022 Earnings Call Transcript

Axonics, Inc. (NASDAQ:AXNX ) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Neil Bhalodkar - VP of IR Raymond Cohen - more_horizontal


Search within

Pages Search Results: